Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Block

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Wiener Klinische Wochenschrift|November 10, 2000
Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosisR Ziesche, L H Block
Trends in Pharmacological Sciences|December 1, 1988
Effect of low LDL not due to role in cholesterol metabolism. Support for 'hormone-like' action of LDLL H Block, A Pletscher
European Journal of Clinical Investigation|June 1, 1990
A new perspective on the antiatherosclerotic activity of Ca2(+)-channel blockersL H Block, L R Emmons
Journal of Pharmaceutical Sciences|April 1, 1973
Solubility and dissolution of triamcinolone acetonideL H Block, R N Patel
Clinical Pharmacology and Therapeutics|June 1, 1980
Effects of aspirin on platelet aggregation as a function of dosage and timeM J Paccioretti, L H Block
Pharmaceutical Research|December 1, 1996
Anionic gels as vehicles for electrically-modulated drug delivery. I. Solvent and drug transport phenomenaC S Hsu, L H Block
Journal of Cardiovascular Pharmacology|January 1, 1992
Atherosclerosis, cell motility, calcium, and calcium-channel blockersL H Block, F R Bühler
Blut|February 19, 1979
Biological and clinical relevance of human macrophage migration inhibitory factor (MIF)L H Block, G Ruhenstroth-Bauer
The Journal of Clinical Investigation|April 1, 1983
Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytesR Locher, W Vetter, L H Block
Deutsche Medizinische Wochenschrift (1946)|August 3, 1984
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis]K Rhyner, M Stenger, L H Block
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Wiener Klinische Wochenschrift|November 10, 2000
Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosisR Ziesche, L H Block
Trends in Pharmacological Sciences|December 1, 1988
Effect of low LDL not due to role in cholesterol metabolism. Support for 'hormone-like' action of LDLL H Block, A Pletscher
European Journal of Clinical Investigation|June 1, 1990
A new perspective on the antiatherosclerotic activity of Ca2(+)-channel blockersL H Block, L R Emmons
Journal of Pharmaceutical Sciences|April 1, 1973
Solubility and dissolution of triamcinolone acetonideL H Block, R N Patel
Clinical Pharmacology and Therapeutics|June 1, 1980
Effects of aspirin on platelet aggregation as a function of dosage and timeM J Paccioretti, L H Block
Pharmaceutical Research|December 1, 1996
Anionic gels as vehicles for electrically-modulated drug delivery. I. Solvent and drug transport phenomenaC S Hsu, L H Block
Journal of Cardiovascular Pharmacology|January 1, 1992
Atherosclerosis, cell motility, calcium, and calcium-channel blockersL H Block, F R Bühler
Blut|February 19, 1979
Biological and clinical relevance of human macrophage migration inhibitory factor (MIF)L H Block, G Ruhenstroth-Bauer
The Journal of Clinical Investigation|April 1, 1983
Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytesR Locher, W Vetter, L H Block
Deutsche Medizinische Wochenschrift (1946)|August 3, 1984
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis]K Rhyner, M Stenger, L H Block
Pageof 10